Adcock Ingram Holdings | AIP - Los Gastos De Explotación



Los Gastos De Explotación Cambio Fecha
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Aspen Pharmacare ZAR 13.32B 5.36B 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Life Healthcare ZAR 11.6B 639M 2025-12
Moderna USD 1.54B 259M 2025-12
Netcare ZAR 11.81B 892M 2025-12
Organon & Co USD 906M 362M 2025-09
Revvity USD 626.22M 25.62M 2025-12
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12